# Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis

> **NCT02602210** · PHASE3 · TERMINATED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 100 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Hydrocortisone
- **DRUG:** NaCL 0.9%

## Key facts

- **NCT ID:** NCT02602210
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Why stopped:** low inclusion rate
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602210, "Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02602210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*